The bulk of its career has been spent in Class 5 company, which is the bread-and-butter level of British racing — competitive enough, but a step or two below the big occasions. Within that sphere, My Rockstar has won 2 from 14 at that level, or about 1 in every 7 races, which is a reasonable return. The partnership with jockey Ben Godfrey is the most interesting thread running through this horse's career. Together they have won 2 from 10 races — that's 1 in every 5, double the horse's overall win rate — which suggests Godfrey genuinely understands how to get the best out of this horse. When the right pair clicks, it can make a real difference, and that record hints at exactly that kind of chemistry.
The two career wins came at Wincanton in April 2023 and then Taunton in November 2024 — nearly 20 months apart, which tells its own story. This is not a horse that rattles off wins in quick succession. The Taunton victory, now 16 months ago, remains the most recent high point. Since then, My Rockstar has gone six races without winning, though a second place and two fifth-place finishes in that run show the horse is still competing, still finishing races, still in the mix even if the winner's enclosure has proven elusive.
Racing today, My Rockstar heads to the track as a horse whose best days in the winner's circle may be behind it — but that would be a premature verdict for a horse that surprised everyone with a win as recently as late 2024. With Ben Godfrey in the saddle, there is at least one combination that has shown it can unlock something extra from this horse. At ten years old, in familiar territory, My Rockstar is exactly the kind of underdog story that keeps racing interesting.
| Course | Races | Results | Last visited | Win rate |
|---|---|---|---|---|
| Wincanton Galloping |
8 | 1 win, 7 other | 1 Apr | 12.5% |
| Taunton Undulating |
7 | 1 win, 1 second, 5 other | 10 Mar | 14.3% |
| Warwick Sharp |
2 | 2 thirds | 30 May | 0% |
| Exeter Undulating |
2 | 2 other | 19 Dec | 0% |
| Fontwell Park Tight |
1 | 1 other | 7 Feb | 0% |